Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of Icagen, Inc. (NASDAQ: ICGN), Pfizer, Inc. (NYSE: PFE), Pain Therapeutics, Inc. (NASDAQ: PTIE), and Zalicus, Inc. (NASDAQ: ZLCS).
Icagen, Inc. (NASDAQ: ICGN) is up more than 150% premarket to $6.10, relative to a 52-week range of $0.93-$4.46. It is rumored that the company may be acquired by Pfizer, Inc. (NYSE: PFE).
Pain Therapeutics, Inc. (NASDAQ: PTIE) is down nearly 25% premarket to $4.00, well below a 52-week range of $4.91-$10.45. Last week, the FDA denied approval of the company’s pain medication.
Zalicus, Inc. (NASDAQ: ZLCS) is up 5% before market open to $2.54, relative to a 52-week range of $1.01-$3.21.
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.